NCT05091346 2025-10-24A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsEisai Inc.Phase 1/2 Completed89 enrolled 24 charts
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled
NCT01133977 2016-10-10E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV MelanomaEisai Inc.Phase 1/2 Completed97 enrolled 8 charts
NCT00121680 2015-12-11A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic MelanomaEisai Inc.Phase 1 Completed115 enrolled